Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Cancer|April 23, 2014
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group studyEmilio Bajetta, Laura Catena, Nicola Fazio, et al.In Vivo (Athens, Greece)|July 2, 2020
Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian CenterPinuccia Faviana, Laura Boldrini, Barbara Musco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancerAntonello Di Paolo, Monica Lencioni, Federica Amatori, et al.Cancer Research|April 6, 2006
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabineElisa Giovannetti, Mario Del Tacca, Valentina Mey, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2007
Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancerSergio Ricci, Giuseppe Boni, Ilaria Pastina, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
Phase II study of sorafenib in patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Lawrence Schwartz, Sergio Ricci, et al.The Lancet. Oncology|September 4, 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind studyGiancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, et al.Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.Annals of Surgical Oncology|April 25, 2012
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancerUday Bharat Patel, Gina Brown, Harm Rutten, et al.Annals of Surgery|February 28, 2009
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastasesGianluca Masi, Fotios Loupakis, Luca Pollina, et al.Pageof 5